Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide ER (Uceris) in Pediatric Ulcerative Colitis
NCT04314375Phase 4Recruiting
- Sponsor
- Valeant Pharmaceuticals
- Start
- Sep 2023
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in ulcerative colitis (UC), sponsored by Valeant Pharmaceuticals. Started Sep 2023; status: recruiting.
02
Drugs
budesonide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04314375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04314375.